Publication | Closed Access
crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer
65
Citations
40
References
2024
Year
Tumor BiologyBreast OncologyMedicineHer2-low Breast CancerCrvdac3 Alleviates FerroptosisHspb1 UbiquitinationBreast CancerRadiation OncologyCancer BiologyCell BiologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1